The company says they have developed an innovative approach, leveraging microarray technology to determine the quantity of microbial content in a sample relative to a specific testing standard.
Cannabinoid drugs do not appear to reduce the intensity of experimental pain, but, instead, may make pain feel less unpleasant and more tolerable.
The lab will move to a centrally located 5,000 square foot facility that to serve marijuana establishments statewide.
Phase I/II clinical trial will be first of its kind to explore cannabis as a potential treatment option for essential tremor.
To date, 6 U.S. states have implemented retail sales of recreational marijuana but none have been able to implement an effective training program for retailers.
Cannabis users experience increased cortical activation during the brain’s resting state when compared with nonusers which may impair brain activity and disrupt cognitive processes.
Study reveals sex-specific effects of prenatal cannabinoid exposure on adult offspring and identifies potential new therapeutic strategies.